GHK-Cu
Early humanNaturally occurring copper-binding tripeptide (matrix-remodeling / skin-regenerative) · Also known as Copper Tripeptide-1, GHK copper peptide, glycyl-L-histidyl-L-lysine copper complex, Cu-GHK
Overview
GHK-Cu is the copper complex of GHK (glycyl-L-histidyl-L-lysine), a tripeptide that occurs naturally in human plasma — roughly 200 ng/mL at age 20, declining to about 80 ng/mL by age 60 — and binds copper with high affinity. In cell and animal models it stimulates collagen, glycosaminoglycan and proteoglycan synthesis, modulates matrix metalloproteinases, has antioxidant activity, and has been reported to up- and down-regulate thousands of human genes. Two very different products are sold under this name and should not be conflated: a TOPICAL cosmetic form (creams/serums) widely available over the counter for skin, and an INJECTABLE 'research' form. The strongest human data is for the topical cosmetic use — small placebo-controlled facial studies (typically ~40–70 women over ~12 weeks) reporting improvements in wrinkle depth, skin density and firmness. There are no large controlled human trials supporting injectable/systemic GHK-Cu for wound healing, hair, or 'anti-aging,' so those claims should be treated as unproven.
Commonly Reported Uses
These are uses commonly discussed or marketed by users and vendors — not a list of proven or approved benefits, and not a recommendation.
- Topical skin anti-aging — wrinkles, firmness, photodamage (cosmetic use; supported by small human studies, not large RCTs)
- Wound healing and skin repair (marketed claim; mostly animal/cell data)
- Injectable 'systemic regeneration' / hair / joint support (marketed claim; human efficacy unproven)
- Hair growth and scalp health in topical formulas (marketed claim; limited human evidence)
What to Track
Data points you and your clinician might monitor. For observation only — not a diagnostic protocol.
- Subjective — daily skin check-ins (texture, firmness, irritation) when using a topical form; standardized progress photos
- Subjective — for injectable research use, log any injection-site reactions, energy, and recovery
- Labs — serum copper / ceruloplasmin if a clinician is monitoring (copper-containing complex; relevant with repeated or high exposure)
- Labs — hs-CRP if a clinician is tracking inflammation for a wound/recovery goal
- Skin — note pigmentation or healing changes around a tracked wound or scar
Sources & References
Quick Reference
- Class
- Naturally occurring copper-binding tripeptide (matrix-remodeling / skin-regenerative)
- Evidence Level
- Early human
- Reported Uses
- 4 listed
- Tracking Metrics
- 5 suggested
- Citations
- 3 sources
Safety & legal notes
The TOPICAL cosmetic form (Copper Tripeptide-1) is sold over the counter as a cosmetic ingredient and is widely used; cosmetics are regulated differently from drugs and are not 'FDA-approved' in the drug sense. The INJECTABLE form is NOT FDA-approved for any human indication and is generally sold 'research use only' / not for human consumption. Copper-containing complexes carry a theoretical risk of copper overload with excessive or repeated systemic exposure. GHK-Cu is not among the most prominent doping targets, but athletes should verify current rules with their governing body before using any injectable peptide. Long-term safety of injectable use is not established. Consult a licensed clinician.
Track your protocol in Peplens
Connect your InBody, Whoop, smart scale, and nutrition data. See your Overlay — all metrics, one clear read.
Get started free →